Suzan A. Khodir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Suzan A. Khodir has a total of 207 co-authors. Here are the top co-authors by number of shared publications:
Noha Abd El-Aziz
Anatomy and Embryology Department, Faculty of Medicine, Menoufia University, Shebin El-Kom, Menoufia, Egypt
26 shared publications- Eman Sweed
Clinical Pharmacology Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt
11 shared publications Asmaa I Bayomi
Zoology Department, Faculty of Science, Menoufia University
7 shared publicationsAmany Elfakhrany
Clinical Pharmacology Department, Faculty of Medicine, Menoufia University, Shebin El-Kom, Menoufia, Egypt
4 shared publicationsMohamed Shebl Amer
Departments Medical Physiology
4 shared publicationsNoha Shawky
Medical Physiology Department, Faculty of Medicine, Helwan University, Egypt
4 shared publications
Latest Publications
- 5 May 2026
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (10) , 1-22
Targeting the PI3K/Akt/mTOR and Nrf2 signaling axis with berberine: a novel strategy for attenuating diabetic cardiomyopathy
Diabetic cardiomyopathy (DCM) is a major contributor to heart failure in patients with diabetes. Although berberine (BBR) exhibits broad metabolic and cardiovascular benefits, its mechanistic role in DCM remains incompletely defined. Cardiovascular function was assessed using arterial blood pressure (ABP), electrocardiography (ECG), and echocardiography. Biochemical analyses included glycemic indices, lipid profile, oxidative stress markers, inflammatory cytokines, and cardiac injury biomarkers. Cardiac and aortic tissues were evaluated for calcium (Ca2⁺) content, gene expression by RT-PCR, and immunohistochemical changes. DCM rats exhibited significant increases in ABP, left ventricular internal diameter, fasting glucose, HbA1c, cholesterol, triglycerides, LDL-C, malondialdehyde, tumor necrosis factor-α, interleukin-17, cardiac enzymes, Caspase-3 expression, and myocardial and aortic fibrosis, accompanied by marked ECG abnormalities. Conversely, ejection fraction, fractional shortening, serum insulin, HDL-C, superoxide dismutase activity, interleukin-10 levels, cardiac Ca2⁺ content, and expression of phosphoinositide 3-kinase (PI3K), protein kinase B (Akt), mammalian target of rapamycin (mTOR), nuclear factor erythroid 2-related factor 2 (Nrf2), and PTEN-induced putative kinase protein 1 (PINK1) were significantly reduced. Combined insulin and BBR treatment produced greater improvement in cardiac structure, function, and molecular signaling than either treatment alone. Berberine, particularly as an adjunct to insulin therapy, effectively attenuates DCM by reducing hyperglycemia, dyslipidemia, oxidative stress, inflammation, fibrosis, and apoptosis, while enhancing mitophagy and cardiac Ca2⁺ homeostasis. These effects are mediated, at least in part, through the coordinated modulation of the PI3K/Akt/mTOR and Nrf2 signaling pathways.
- 5 May 2026
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 399 (10) , 1-22
Targeting the PI3K/Akt/mTOR and Nrf2 signaling axis with berberine: a novel strategy for attenuating diabetic cardiomyopathy
Diabetic cardiomyopathy (DCM) is a major contributor to heart failure in patients with diabetes. Although berberine (BBR) exhibits broad metabolic and cardiovascular benefits, its mechanistic role in DCM remains incompletely defined. Cardiovascular function was assessed using arterial blood pressure (ABP), electrocardiography (ECG), and echocardiography. Biochemical analyses included glycemic indices, lipid profile, oxidative stress markers, inflammatory cytokines, and cardiac injury biomarkers. Cardiac and aortic tissues were evaluated for calcium (Ca2⁺) content, gene expression by RT-PCR, and immunohistochemical changes. DCM rats exhibited significant increases in ABP, left ventricular internal diameter, fasting glucose, HbA1c, cholesterol, triglycerides, LDL-C, malondialdehyde, tumor necrosis factor-α, interleukin-17, cardiac enzymes, Caspase-3 expression, and myocardial and aortic fibrosis, accompanied by marked ECG abnormalities. Conversely, ejection fraction, fractional shortening, serum insulin, HDL-C, superoxide dismutase activity, interleukin-10 levels, cardiac Ca2⁺ content, and expression of phosphoinositide 3-kinase (PI3K), protein kinase B (Akt), mammalian target of rapamycin (mTOR), nuclear factor erythroid 2-related factor 2 (Nrf2), and PTEN-induced putative kinase protein 1 (PINK1) were significantly reduced. Combined insulin and BBR treatment produced greater improvement in cardiac structure, function, and molecular signaling than either treatment alone. Berberine, particularly as an adjunct to insulin therapy, effectively attenuates DCM by reducing hyperglycemia, dyslipidemia, oxidative stress, inflammation, fibrosis, and apoptosis, while enhancing mitophagy and cardiac Ca2⁺ homeostasis. These effects are mediated, at least in part, through the coordinated modulation of the PI3K/Akt/mTOR and Nrf2 signaling pathways.
- 25 November 2025
- Published by Egyptian Knowledge Bank in Medicine Updates
Luteolin attenuates Doxorubicin-Induced Cardiac Toxicity in Rats by downregulation of TLR4/NF-kB signaling pathway
Background: the use of doxorubicin (Dox), anticancer antibiotic, has been restricted due to its potential toxicity to critical organs, such as the heart. Strong anti-inflammatory and anti-oxidant properties are exhibited by luteolin (Lut).Aim of the study: to demonstrate the cardiac protective effect of Lut in DOX-induced cardiotoxicity and the underlying processes. Material and methods: Three groups of thirty male albino rats were created: DOX, DOX+Lut, and control (10/group). Serum cTnI, serum LDH, serum CK-MB, serum lipid, cardiac MDA, cardiac SOD, cardiac TNF-α, cardiac IL-6, cardiac IL-10, cardiac TLR4 gene expression, and cardiac NF-kB gene expression were all measured. Cardiac immunohistochemistry analyses were also carried out.Results: Serum cTnI, serum LDH, serum CK-MB, serum cholesterol, serum triglycerides, cardiac MDA, cardiac TNF-α, cardiac IL-6, cardiac gene expression of TLR4 and NF-kB, and cardiac caspase-3 & NF-kB immunoreaction were all substantially higher in the DOX than in the control, while decreased cardiac index value, cardiac SOD, and cardiac IL-10. Lut substantially reduced the cardiac alterations brought on by DOX.Conclusion: By downregulating the cardiac TLR4/NF-kB pathway and exhibiting anti-inflammatory, antiapoptotic, antioxidant, and lipid-lowering properties, Lut has a cardio-protective effect in DOX rats.
- 25 November 2025
- Published by Egyptian Knowledge Bank in Medicine Updates
Luteolin attenuates Doxorubicin-Induced Cardiac Toxicity in Rats by downregulation of TLR4/NF-kB signaling pathway
Background: the use of doxorubicin (Dox), anticancer antibiotic, has been restricted due to its potential toxicity to critical organs, such as the heart. Strong anti-inflammatory and anti-oxidant properties are exhibited by luteolin (Lut).Aim of the study: to demonstrate the cardiac protective effect of Lut in DOX-induced cardiotoxicity and the underlying processes. Material and methods: Three groups of thirty male albino rats were created: DOX, DOX+Lut, and control (10/group). Serum cTnI, serum LDH, serum CK-MB, serum lipid, cardiac MDA, cardiac SOD, cardiac TNF-α, cardiac IL-6, cardiac IL-10, cardiac TLR4 gene expression, and cardiac NF-kB gene expression were all measured. Cardiac immunohistochemistry analyses were also carried out.Results: Serum cTnI, serum LDH, serum CK-MB, serum cholesterol, serum triglycerides, cardiac MDA, cardiac TNF-α, cardiac IL-6, cardiac gene expression of TLR4 and NF-kB, and cardiac caspase-3 & NF-kB immunoreaction were all substantially higher in the DOX than in the control, while decreased cardiac index value, cardiac SOD, and cardiac IL-10. Lut substantially reduced the cardiac alterations brought on by DOX.Conclusion: By downregulating the cardiac TLR4/NF-kB pathway and exhibiting anti-inflammatory, antiapoptotic, antioxidant, and lipid-lowering properties, Lut has a cardio-protective effect in DOX rats.
- 25 November 2025
- Published by Egyptian Knowledge Bank in Medicine Updates
Amentoflavone attenuates Indomethacin-Induced Gastric Ulcer in Rats by up-regulation of Nrf2/HO-1 signaling pathway
Background: One of common gastrointestinal conditions in the world is peptic ulcers. Indomethacin (IND) has a higher tendency to cause ulcers. Amentoflavone (AMF) has anti-inflammatory, anti-apoptotic, and antioxidant qualities.Objective: The goal of the study was to asses the gastroprotective impact of AMF in IND-induced stomach ulcers and underlying processes. Material and Methods: Thirty male albino rats were divided into: control, Ulcer, and Ulcer+ AMF. Gastric ulcer index values, gastric PH, gastric PGE2, gastric MDA, gastric SOD, gastric TNF-α, gastric IL-1β, gastric IL-10, and gastric Nrf2 and HO-1 gene expression were assessed. Histopathologic and NF-kB and Bax immunohistochemical analyses of the gastric tissue were also carried out. Results: compared to control, the ulcer group exhibited significantly higher gastric ulcer index values, gastric MDA, gastric TNF-α, gastric IL-1β, and gastric NF-kB and Bax immunoreaction, while gastric PH values, gastric SOD, gastric IL-10, and gastric PGE2, as well as gastric gene expression of Nrf2 and HO-1 were dramatically decreased. AMF significantly reduced the alterations in stomach tissue brought on by IND.Conclusion: Through its antioxidant, anti-inflammatory, and anti-apoptotic qualities and upregulating the Nrf2/HO-1 signaling pathway, AMF exhibits gastroprotective benefits in rats with IND-induced ulcers.
- 25 November 2025
- Published by Egyptian Knowledge Bank in Medicine Updates
Amentoflavone attenuates Indomethacin-Induced Gastric Ulcer in Rats by up-regulation of Nrf2/HO-1 signaling pathway
Background: One of common gastrointestinal conditions in the world is peptic ulcers. Indomethacin (IND) has a higher tendency to cause ulcers. Amentoflavone (AMF) has anti-inflammatory, anti-apoptotic, and antioxidant qualities.Objective: The goal of the study was to asses the gastroprotective impact of AMF in IND-induced stomach ulcers and underlying processes. Material and Methods: Thirty male albino rats were divided into: control, Ulcer, and Ulcer+ AMF. Gastric ulcer index values, gastric PH, gastric PGE2, gastric MDA, gastric SOD, gastric TNF-α, gastric IL-1β, gastric IL-10, and gastric Nrf2 and HO-1 gene expression were assessed. Histopathologic and NF-kB and Bax immunohistochemical analyses of the gastric tissue were also carried out. Results: compared to control, the ulcer group exhibited significantly higher gastric ulcer index values, gastric MDA, gastric TNF-α, gastric IL-1β, and gastric NF-kB and Bax immunoreaction, while gastric PH values, gastric SOD, gastric IL-10, and gastric PGE2, as well as gastric gene expression of Nrf2 and HO-1 were dramatically decreased. AMF significantly reduced the alterations in stomach tissue brought on by IND.Conclusion: Through its antioxidant, anti-inflammatory, and anti-apoptotic qualities and upregulating the Nrf2/HO-1 signaling pathway, AMF exhibits gastroprotective benefits in rats with IND-induced ulcers.
- Open Access
- 4 November 2025
- Published by Egyptian Knowledge Bank in Bulletin of Egyptian Society for Physiological Sciences
Resveratrol mitigates Valproic Acid-Induced Autistic Features in mice via up-regulation of Nrf2/HO-1 signaling pathway
Introduction: A neurodevelopmental disease known as autism spectrum disorder (ASD) is linked to stereotypical behavior and poor social skills. Resveratrol (Res) has been shown to possess anti-inflammatory and antioxidant impacts.Objective: to demonstrate the underlying mechanisms and neuroprotective impact of Res in VPA-induced ASDMaterial & methods: Thirty male Swiss mice were split into three : control, VPA, and VPA+Res. Following neurobehavioral testing, the rats were sacrificed, and the cerebellar gene expression of Nrf2 and HO-1 was evaluated together with the measurements of MDA, SOD, TNF-α, IL-6, IL-10 and serotonin. GFAP and Caspase-3 cerebellar immunoreactions were performed. Results: While the VPA group's time of central crossing in OFT, percentage of alternation in the T maze test, Cerebellar SOD, Cerebellar IL-10, and Cerebellar gene expression of Nrf2 and HO-1 were dramatically lower than those of the control, the VPA 's number of crossing slots in OFT, rearing frequency in OFT, Cerebellar MDA, Cerebellar TNF-α, and Cerebellar IL-6 were all dramatically higher than those of the control group with impairments in social interaction. Res substantially reduced VPA-induced ASD.Conclusion: In addition to enhancing gliosis and up-regulating the Nrf2/HO-1 signaling pathway, Res also reduced VPA-induced ASD through anti-oxidant, anti-inflammatory and antiapoptotic pathways.
- 4 November 2025
- Published by Egyptian Knowledge Bank in Bulletin of Egyptian Society for Physiological Sciences
Open AccessResveratrol mitigates Valproic Acid-Induced Autistic Features in mice via up-regulation of Nrf2/HO-1 signaling pathway
Introduction: A neurodevelopmental disease known as autism spectrum disorder (ASD) is linked to stereotypical behavior and poor social skills. Resveratrol (Res) has been shown to possess anti-inflammatory and antioxidant impacts.Objective: to demonstrate the underlying mechanisms and neuroprotective impact of Res in VPA-induced ASDMaterial & methods: Thirty male Swiss mice were split into three : control, VPA, and VPA+Res. Following neurobehavioral testing, the rats were sacrificed, and the cerebellar gene expression of Nrf2 and HO-1 was evaluated together with the measurements of MDA, SOD, TNF-α, IL-6, IL-10 and serotonin. GFAP and Caspase-3 cerebellar immunoreactions were performed. Results: While the VPA group's time of central crossing in OFT, percentage of alternation in the T maze test, Cerebellar SOD, Cerebellar IL-10, and Cerebellar gene expression of Nrf2 and HO-1 were dramatically lower than those of the control, the VPA 's number of crossing slots in OFT, rearing frequency in OFT, Cerebellar MDA, Cerebellar TNF-α, and Cerebellar IL-6 were all dramatically higher than those of the control group with impairments in social interaction. Res substantially reduced VPA-induced ASD.Conclusion: In addition to enhancing gliosis and up-regulating the Nrf2/HO-1 signaling pathway, Res also reduced VPA-induced ASD through anti-oxidant, anti-inflammatory and antiapoptotic pathways.
- Open Access
- 4 November 2025
- Published by Egyptian Knowledge Bank in Bulletin of Egyptian Society for Physiological Sciences
Baicalein mitigates cognitive impairment in chronic stress rat model by downregulating TLR4/NF-kB signaling pathway
Introduction: Chronic stress can significantly impair memory and learning processes by changing the hippocampus and other brain regions. Baicalein (Baic) has been shown to possess anti-inflammatory and antioxidant qualities.Objective: to demonstrate the neuroprotective mechanism of Baic in stress-induced cognitive impairments.Material & methods: Thirty male Wister albino rats were split into three: control, stress, and stress + bait. Rats underwent NOR and EPM tests, hippocampus gene expression of TLR4, NF-kB, and BDNF was evaluated, and serum corticosterone, hippocampal MDA, SOD, TNF-α, and IL-6 were examined. TLR4 and NF-kB immunoreaction for hippocampus were performed. Results: In contrast to the control group, which had higher hippocampal TLR4 and NF-kB immunoreaction and a significantly lower discrimination index of the NOR test, time in the open arms of EPM, SOD, and gene expression of BDNF, stress demonstrated cognitive impairment by significantly increasing serum corticosterone, hippocampal MDA, TNF-α, IL-6, and hippocampal gene expression of TLR4 and NF-kB. Baic significantly improved the alterations in the brain caused by stress. Conclusion: Baic reduced stress-induced cognitive deficits by down-regulation of the TLR4/NF-kB signaling pathway as well as neurotrophic, antioxidant, and anti-inflammatory mechanisms.
- 4 November 2025
- Published by Egyptian Knowledge Bank in Bulletin of Egyptian Society for Physiological Sciences
Open AccessBaicalein mitigates cognitive impairment in chronic stress rat model by downregulating TLR4/NF-kB signaling pathway
Introduction: Chronic stress can significantly impair memory and learning processes by changing the hippocampus and other brain regions. Baicalein (Baic) has been shown to possess anti-inflammatory and antioxidant qualities.Objective: to demonstrate the neuroprotective mechanism of Baic in stress-induced cognitive impairments.Material & methods: Thirty male Wister albino rats were split into three: control, stress, and stress + bait. Rats underwent NOR and EPM tests, hippocampus gene expression of TLR4, NF-kB, and BDNF was evaluated, and serum corticosterone, hippocampal MDA, SOD, TNF-α, and IL-6 were examined. TLR4 and NF-kB immunoreaction for hippocampus were performed. Results: In contrast to the control group, which had higher hippocampal TLR4 and NF-kB immunoreaction and a significantly lower discrimination index of the NOR test, time in the open arms of EPM, SOD, and gene expression of BDNF, stress demonstrated cognitive impairment by significantly increasing serum corticosterone, hippocampal MDA, TNF-α, IL-6, and hippocampal gene expression of TLR4 and NF-kB. Baic significantly improved the alterations in the brain caused by stress. Conclusion: Baic reduced stress-induced cognitive deficits by down-regulation of the TLR4/NF-kB signaling pathway as well as neurotrophic, antioxidant, and anti-inflammatory mechanisms.
- 22 October 2025
- Published by Egyptian Knowledge Bank in Medicine Updates
Astaxanthin attenuates diabetic cardiomyopathy in rats by downregulation of HMGB1/TLR4/NF-kB signaling pathway
Background: Cardiomyocyte inflammation, oxidative stress, and myocardial metabolic disruption are among the pathologic abnormalities that can result from diabetic cardiomyopathy (DCM), an independent diabetic cardiac disease. Astaxanthin (ASX) possesses anti-inflammatory and antioxidant properties. Objective: to demonstrate the potential underlying mechanisms and cardioprotective impact of ASX in DCM. Material and methods: Thirty male rats were split into: DCM, DCM+ASX, and control (10/group). Evaluations of the following were conducted: tibial length/LVW, Serum cTnI, LDH, CK-MB, glycosylated Hb A1c, Cholesterol and Triglyceride, HOMA-IR index, and Cardiac MDA, SOD, TNF-α, IL-6, IL-10 and Cardiac gene expression of HMGB1, TLR4, and NF-kB. Additionally, the heart was examined histologically and immunohistochemically. Results: The DCM group's cardiac SOD and cardiac IL-10 were dramatically lower than control, but the measured LVW/tibial length, serum glucose, serum insulin, HOMA-IR index, serum glycosylated Hb A1c, serum cholesterol, serum triglyceride, serum cTnI, serum LDH, serum CK-MB, cardiac MDA, cardiac TNF-α, cardiac IL-6, and cardiac gene expression of HMGB1, TLR4, and NF-kB were all dramatically higher in the DCM than the control. The DCM group's TLR4 and NF-kB cardiac immunoreaction was dramatically lower than the control group's. ASX considerably reduced the alterations brought on by diabetic cardiomyopathy.Conclusion: ASX ameliorated diabetic cardiomyopathy by inhibiting the cardiac HMGB1/TLR4/NF-kB signaling cascade and demonstrating anti-inflammatory, antioxidant, hypoglycemic, and lipid-lowering qualities.
- 22 October 2025
- Published by Egyptian Knowledge Bank in Medicine Updates
Astaxanthin attenuates diabetic cardiomyopathy in rats by downregulation of HMGB1/TLR4/NF-kB signaling pathway
Background: Cardiomyocyte inflammation, oxidative stress, and myocardial metabolic disruption are among the pathologic abnormalities that can result from diabetic cardiomyopathy (DCM), an independent diabetic cardiac disease. Astaxanthin (ASX) possesses anti-inflammatory and antioxidant properties. Objective: to demonstrate the potential underlying mechanisms and cardioprotective impact of ASX in DCM. Material and methods: Thirty male rats were split into: DCM, DCM+ASX, and control (10/group). Evaluations of the following were conducted: tibial length/LVW, Serum cTnI, LDH, CK-MB, glycosylated Hb A1c, Cholesterol and Triglyceride, HOMA-IR index, and Cardiac MDA, SOD, TNF-α, IL-6, IL-10 and Cardiac gene expression of HMGB1, TLR4, and NF-kB. Additionally, the heart was examined histologically and immunohistochemically. Results: The DCM group's cardiac SOD and cardiac IL-10 were dramatically lower than control, but the measured LVW/tibial length, serum glucose, serum insulin, HOMA-IR index, serum glycosylated Hb A1c, serum cholesterol, serum triglyceride, serum cTnI, serum LDH, serum CK-MB, cardiac MDA, cardiac TNF-α, cardiac IL-6, and cardiac gene expression of HMGB1, TLR4, and NF-kB were all dramatically higher in the DCM than the control. The DCM group's TLR4 and NF-kB cardiac immunoreaction was dramatically lower than the control group's. ASX considerably reduced the alterations brought on by diabetic cardiomyopathy.Conclusion: ASX ameliorated diabetic cardiomyopathy by inhibiting the cardiac HMGB1/TLR4/NF-kB signaling cascade and demonstrating anti-inflammatory, antioxidant, hypoglycemic, and lipid-lowering qualities.
- 21 October 2025
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 132 (3) , 288-304
Vit D mitigates metabolic syndrome-induced hepatic damage via antioxidant, anti-inflammatory, and AMPK/PI3K signaling pathways in rats
Metabolic syndrome (MetS) involves insulin resistance and dyslipidemia. To evaluate vitamin D's (Vit D) hepatoprotective role in MetS and its mechanisms. Thirty male rats were divided into MetS, MetS + Vit D, and control groups. We measured arterial blood pressure (ABP), body weight, fat, homeostatic Model Assessment for Insulin Resistance (HOMA-IR), glycemic/lipid profiles, liver enzymes, oxidative stress (Malondialdehyde, superoxide dismutase), inflammation (Tumor necrosis factor; TNF-α, matrix metalloproteinase; MMP9, Glial fibrillary acidic protein; GFAP), and AMP-activated protein kinase/Phosphoinositide 3-kinase (AMPK/PI3K) expression. MetS increased oxidative stress, TNF-α, liver enzymes, HOMA-IR, and ABP while reducing adiponectin and AMPK/PI3K. Vit D reversed these effects, suppressing GFAP/MMP9 and restoring metabolic balance. Conclusion: Vit D mitigates MetS-induced liver damage via AMPK/PI3K activation, exerting antioxidant and anti-inflammatory effects.
- 21 October 2025
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 132 (3) , 288-304
Vit D mitigates metabolic syndrome-induced hepatic damage via antioxidant, anti-inflammatory, and AMPK/PI3K signaling pathways in rats
Metabolic syndrome (MetS) involves insulin resistance and dyslipidemia. To evaluate vitamin D's (Vit D) hepatoprotective role in MetS and its mechanisms. Thirty male rats were divided into MetS, MetS + Vit D, and control groups. We measured arterial blood pressure (ABP), body weight, fat, homeostatic Model Assessment for Insulin Resistance (HOMA-IR), glycemic/lipid profiles, liver enzymes, oxidative stress (Malondialdehyde, superoxide dismutase), inflammation (Tumor necrosis factor; TNF-α, matrix metalloproteinase; MMP9, Glial fibrillary acidic protein; GFAP), and AMP-activated protein kinase/Phosphoinositide 3-kinase (AMPK/PI3K) expression. MetS increased oxidative stress, TNF-α, liver enzymes, HOMA-IR, and ABP while reducing adiponectin and AMPK/PI3K. Vit D reversed these effects, suppressing GFAP/MMP9 and restoring metabolic balance. Conclusion: Vit D mitigates MetS-induced liver damage via AMPK/PI3K activation, exerting antioxidant and anti-inflammatory effects.
- Open Access
- 1 October 2025
- Published by Egyptian Knowledge Bank in Bulletin of Egyptian Society for Physiological Sciences
- Vol. 45 (4) , 519-531
The Renin Inhibitor Aliskiren mitigates Diabetes mellitus induced Vascular Impairment of rats
Background: The most prevalent kind of diabetes is type 2 diabetes mellitus (T2DM). Vascular impairment is one of the numerous problems that frequently accompany diabetes mellitus. Renin inhibitors like Aliskiren have been shown to effectively protect organs through a variety of methods.Objective: to illustrate aliskiren's vascular-protective effects in diabetic rats and any possible underlying processes at play.Material and methods: Thirty male albino rats were split into three groups: diabetic, diabetic+aliskiren, and control (10/group). Serum glucose, insulin, HOMA-IR index, glycosylated Hb A1c, cholesterol, triglycerides, renin activity, aortic MDA, aortic SOD, aortic TNF-α, aortic IL-6, aortic IL-10, aortic NF-kB gene expression, and aortic ENOS gene expression were all evaluated. Additionally, aortic histology and immunohistochemical analyses were performed. Results: In contrast to the control group, the diabetic group's aortic SOD, aortic IL-10, and aortic gene expression of ENOS were significantly lower, while the measured serum glucose, insulin, HOMA-IR index, serum glycosylated Hb A1c, serum cholesterol, serum triglyceride, serum renin activity, aortic MDA, aortic TNF-α, aortic IL-6, and aortic gene expression of NF-kB were all significantly higher in the diabetic group. Additionally, as compared to the control group, the diabetic group's aortic ENOS was significantly downregulated and their aortic NF-kB immunoreaction was elevated. Aliskiren considerably reduced the vascular alterations brought on by diabetes.Conclusion: By blocking renin activity and exhibiting hypoglycemic, lipid-lowering, anti-inflammatory, and antioxidant effects in addition to upregulating aortic ENOS, aliskiren guards against diabetes-induced vascular damage.
- 1 October 2025
- Published by Egyptian Knowledge Bank in Bulletin of Egyptian Society for Physiological Sciences
- Vol. 45 (4) , 519-531
Open AccessThe Renin Inhibitor Aliskiren mitigates Diabetes mellitus induced Vascular Impairment of rats
Background: The most prevalent kind of diabetes is type 2 diabetes mellitus (T2DM). Vascular impairment is one of the numerous problems that frequently accompany diabetes mellitus. Renin inhibitors like Aliskiren have been shown to effectively protect organs through a variety of methods.Objective: to illustrate aliskiren's vascular-protective effects in diabetic rats and any possible underlying processes at play.Material and methods: Thirty male albino rats were split into three groups: diabetic, diabetic+aliskiren, and control (10/group). Serum glucose, insulin, HOMA-IR index, glycosylated Hb A1c, cholesterol, triglycerides, renin activity, aortic MDA, aortic SOD, aortic TNF-α, aortic IL-6, aortic IL-10, aortic NF-kB gene expression, and aortic ENOS gene expression were all evaluated. Additionally, aortic histology and immunohistochemical analyses were performed. Results: In contrast to the control group, the diabetic group's aortic SOD, aortic IL-10, and aortic gene expression of ENOS were significantly lower, while the measured serum glucose, insulin, HOMA-IR index, serum glycosylated Hb A1c, serum cholesterol, serum triglyceride, serum renin activity, aortic MDA, aortic TNF-α, aortic IL-6, and aortic gene expression of NF-kB were all significantly higher in the diabetic group. Additionally, as compared to the control group, the diabetic group's aortic ENOS was significantly downregulated and their aortic NF-kB immunoreaction was elevated. Aliskiren considerably reduced the vascular alterations brought on by diabetes.Conclusion: By blocking renin activity and exhibiting hypoglycemic, lipid-lowering, anti-inflammatory, and antioxidant effects in addition to upregulating aortic ENOS, aliskiren guards against diabetes-induced vascular damage.
- 30 August 2025
- Published by Egyptian Knowledge Bank in Medicine Updates
Quercetin alleviates Valproic Acid-Induced Autistic Features in mice via down-regulation of TLR4/NF-κB signaling pathway
Introduction: Autism spectrum disorder (ASD) is linked to stereotypical behavior and poor social skills. Quercetin (Qrct) has been shown to possess anti-inflammatory and antioxidant impacts.Objective: to demonstrate the underlying processes and the neuroprotective impact of Qrct in VPA-induced ASD.Material & methods: Thirty male Wister albino rats were split into three: control, VPA, and VPA+ Qrct. Following neurobehavioral testing, the rats were sacrificed, and the cerebellar gene expression of TLR4 and NF-kB was evaluated together with the measurements of cerebellar MDA, SOD, TNF-α, IL-6, IL-10, BDNF, and serotonin. Cerebellar and histopathological immunoreactions for Bax and NF-kB were performed. Results: While the VPA group's number of crossing slots in OFT, time of central crossing in OFT, cerebellar SOD, cerebellar IL-10, cerebellar BDNF, and cerebellar serotonin were dramatically decreased than those of the control, the VPA group's rearing frequency in OFT, time in the open arms of EPM, cerebellar MDA, cerebellar TNF-α, cerebellar IL-6 and cerebellar TLR4 and NF-kB gene expression dramatically increased than those of the control. Additionally, the VPA group's NF-kB and Bax cerebellar immunoreaction were dramatically increased than those of the control. Qrct significantly enhanced ASD caused by VPA.Conclusion: Qrct reduced VPA-induced ASD by down-regulation of the cerebellar TLR4/NF-kB pathway as well as anti-oxidant, anti-inflammatory, neurotropic, and antiapoptotic pathways.
- 30 August 2025
- Published by Egyptian Knowledge Bank in Medicine Updates
Quercetin alleviates Valproic Acid-Induced Autistic Features in mice via down-regulation of TLR4/NF-κB signaling pathway
Introduction: Autism spectrum disorder (ASD) is linked to stereotypical behavior and poor social skills. Quercetin (Qrct) has been shown to possess anti-inflammatory and antioxidant impacts.Objective: to demonstrate the underlying processes and the neuroprotective impact of Qrct in VPA-induced ASD.Material & methods: Thirty male Wister albino rats were split into three: control, VPA, and VPA+ Qrct. Following neurobehavioral testing, the rats were sacrificed, and the cerebellar gene expression of TLR4 and NF-kB was evaluated together with the measurements of cerebellar MDA, SOD, TNF-α, IL-6, IL-10, BDNF, and serotonin. Cerebellar and histopathological immunoreactions for Bax and NF-kB were performed. Results: While the VPA group's number of crossing slots in OFT, time of central crossing in OFT, cerebellar SOD, cerebellar IL-10, cerebellar BDNF, and cerebellar serotonin were dramatically decreased than those of the control, the VPA group's rearing frequency in OFT, time in the open arms of EPM, cerebellar MDA, cerebellar TNF-α, cerebellar IL-6 and cerebellar TLR4 and NF-kB gene expression dramatically increased than those of the control. Additionally, the VPA group's NF-kB and Bax cerebellar immunoreaction were dramatically increased than those of the control. Qrct significantly enhanced ASD caused by VPA.Conclusion: Qrct reduced VPA-induced ASD by down-regulation of the cerebellar TLR4/NF-kB pathway as well as anti-oxidant, anti-inflammatory, neurotropic, and antiapoptotic pathways.
- 30 August 2025
- Published by Egyptian Knowledge Bank in Medicine Updates
Melatonin alleviates cisplatin induced liver toxicity in rats by up-regulation of Nrf2/HO-1 signaling pathway
Background: One of the most well-known chemotherapy drugs is cisplatin (Cis). Hepatotoxicity is among the most significant adverse effects of cisplatin. The pineal gland hormone melatonin (Mel) is primarily reliant on the light/dark cycle for its cyclic release. This neurohormone can preserve tissue redox equilibrium and functions as an antioxidant.Aim: The purpose of the study was to assess hepatoprotective impact of Mel in rats exposed to Cis, as well as any possible underlying processes.Methods: Three groups of thirty adult male albino rats were created: control, Cis, and Cis+Mel. Hepatic MDA, hepatic SOD, hepatic TNF-α, hepatic IL-6, hepatic IL-10, liver-expressed Nrf2 and HO-1 genes and serum liver enzymes were measured. Additional assessments of the liver's caspase-3 and NF-kB immunoreaction were conducted.Results: Hepatic SOD, IL-10, and Nrf2 and HO-1 gene expression all significantly decline in response to cis-induced damage. Nevertheless, as compared to control, there was a notable rise in serum liver enzymes along with hepatic MDA, TNF-α, and IL-6, along with an upregulation of caspase-3 and NF-kB immunoreaction in the liver. Mel significantly improved the liver abnormalities brought on by Cis.Conclusion: Mel employed anti-oxidant, anti-inflammatory, and anti-apoptotic mechanisms in addition to up-regulating the Nrf2/HO-1 signaling cascade to reduce the hepatotoxicity brought on by Cis.
- 30 August 2025
- Published by Egyptian Knowledge Bank in Medicine Updates
Melatonin alleviates cisplatin induced liver toxicity in rats by up-regulation of Nrf2/HO-1 signaling pathway
Background: One of the most well-known chemotherapy drugs is cisplatin (Cis). Hepatotoxicity is among the most significant adverse effects of cisplatin. The pineal gland hormone melatonin (Mel) is primarily reliant on the light/dark cycle for its cyclic release. This neurohormone can preserve tissue redox equilibrium and functions as an antioxidant.Aim: The purpose of the study was to assess hepatoprotective impact of Mel in rats exposed to Cis, as well as any possible underlying processes.Methods: Three groups of thirty adult male albino rats were created: control, Cis, and Cis+Mel. Hepatic MDA, hepatic SOD, hepatic TNF-α, hepatic IL-6, hepatic IL-10, liver-expressed Nrf2 and HO-1 genes and serum liver enzymes were measured. Additional assessments of the liver's caspase-3 and NF-kB immunoreaction were conducted.Results: Hepatic SOD, IL-10, and Nrf2 and HO-1 gene expression all significantly decline in response to cis-induced damage. Nevertheless, as compared to control, there was a notable rise in serum liver enzymes along with hepatic MDA, TNF-α, and IL-6, along with an upregulation of caspase-3 and NF-kB immunoreaction in the liver. Mel significantly improved the liver abnormalities brought on by Cis.Conclusion: Mel employed anti-oxidant, anti-inflammatory, and anti-apoptotic mechanisms in addition to up-regulating the Nrf2/HO-1 signaling cascade to reduce the hepatotoxicity brought on by Cis.